Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (ChiCTR2600132705) titled 'Application of Quantitative Third Harmonic Generation Microscopy imaging in the pathological diagnosis of orbital tumors' on Sept. 17.

Study Type: Observational study

Study Design: Cross-sectional

Primary Sponsor: Tianjin Medical University Eye Hospital

Condition: Meibomian gland carcinoma

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2026-09-22

Target Sample Size: Observation group:20;

Countries of Recruitment: China

To know more, visit https://www.chictr.org.cn/showproj.html?proj=340854

Published by HT Digital Content Services with permission from Health Daily Digest....